References
- World Health Organization. Coronavirus disease 2019 situation report 195 [Internet]. 2020. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports [last accessed 3 September 2020].
- Massachusetts Department of Public Health. COVID-19 dashboard 2020 [Internet]. 2020. https://www.mass.gov/doc/covid-19-dashboard-june-5-2020/download [last accessed 3 September 2020].
- Busse WW, Lemanske RF, Jr, Gern JE. Role of viral respiratory infections in asthma and asthma exacerbations. Lancet 2010;376(9743):826–834. doi:https://doi.org/10.1016/S0140-6736(10)61380-3.
- Yin Y, Wunderink RG. MERS, SARS and other coronaviruses as causes of pneumonia. Respirology 2018;23(2):130–137. doi:https://doi.org/10.1111/resp.13196.
- Hui DS, Azhar EI, Kim YJ, Memish ZA, Oh MD, Zumla A. Middle East respiratory syndrome coronavirus: risk factors and determinants of primary, household, and nosocomial transmission. Lancet Infect Dis. 2018;18(8):e217–e27. doi:https://doi.org/10.1016/S1473-3099(18)30127-0.
- Beurnier A, Jutant E-M, Jevnikar M, Boucly A, Pichon J, Preda M, Frank M, Laurent J, Richard C, Monnet X, et al. Characteristics and outcomes of asthmatic patients with COVID-19 pneumonia who require hospitalisation. Eur Respir J. 2020;56(5):2001875. doi:https://doi.org/10.1183/13993003.01875-2020.
- Goyal P, Choi JJ, Pinheiro LC, Schenck EJ, Chen R, Jabri A, Satlin MJ, Campion TR, Nahid M, Ringel JB, et al. Clinical characteristics of Covid-19 in New York City. N Engl J Med. 2020;382(24):2372–2374. doi:https://doi.org/10.1056/NEJMc2010419.
- Butler MW, O'Reilly A, Dunican EM, Mallon P, Feeney ER, Keane MP, McCarthy C. Prevalence of comorbid asthma in COVID-19 patients. J Allergy Clin Immunol. 2020;146(2):334–335. doi:https://doi.org/10.1016/j.jaci.2020.04.061.
- Centers for Disease Control and Prevention. National Current Asthma Prevalence (2018) [Internet]. 2020. Available from: https://www.cdc.gov/asthma/most_recent_national_asthma_data.htm [last reviewed March 2020; last accessed 3 September 2020].
- Nalichowski R, Keogh D, Chueh HC, Murphy SN. Calculating the benefits of a Research Patient Data Repository. AMIA Annu Symp Proc. 2006. 2006:1044.
- Glasheen WP, Cordier T, Gumpina R, Haugh G, Davis J, Renda A. Charlson comorbidity index: ICD-9 update and ICD-10 translation. Am Health Drug Benefits 2019;12(4):188–197.
- Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383. doi:https://doi.org/10.1016/0021-9681(87)90171-8.
- Li X, Xu S, Yu M, Wang K, Tao Y, Zhou Y, Shi J, Zhou M, Wu B, Yang Z, et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol. 2020;146(1):110–118. doi:https://doi.org/10.1016/j.jaci.2020.04.006.
- Zhang J-j, Dong X, Cao Y-y, Yuan Y-d, Yang Y-b, Yan Y-q, Akdis CA, Gao Y-d. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020;75(7):1730–1741. doi:https://doi.org/10.1111/all.14238.
- Halpin DMG, Faner R, Sibila O, Badia JR, Agusti A. Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection? Lancet Respir Med. 2020;8(5):436–438. doi:https://doi.org/10.1016/S2213-2600(20)30167-3.
- Centers for Disease Control and Prevention. Coronavirus Disease 2019 (COVID-19): People at increased risk of severe illness [Internet]. 2020. Available from: https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-at-increased-risk.html [updated June 2020; last accessed 3 September 2020].
- Lieberman-Cribbin W, Rapp J, Alpert N, Tuminello S, Taioli E. The impact of asthma on mortality in patients with COVID-19. Chest 2020;S0012-3692(20):31645–31647. doi:https://doi.org/10.1016/j.chest.2020.05.575.
- Lovinsky-Desir S, Deshpande DR, De A, Murray L, Stingone JA, Chan A, Patel N, Rai N, DiMango E, Milner J, et al. Asthma among hospitalized patients with COVID-19 and related outcomes. J Allergy Clin Immunol. 2020;146(5):1027–1034.e4. doi:https://doi.org/10.1016/j.jaci.2020.07.026.
- Broadhurst R, Peterson R, Wisnivesky JP, Federman A, Zimmer SM, Sharma S, Wechsler M, Holguin F. Asthma in COVID-19 hospitalizations: an overestimated risk factor? Ann Am Thorac Soc 2020;17(12):1645–1648. doi:https://doi.org/10.1513/AnnalsATS.202006-613RL.
- Chhiba KD, Patel GB, Vu THT, Chen MM, Guo A, Kudlaty E, Mai Q, Yeh C, Muhammad LN, Harris KE, et al. Prevalence and characterization of asthma in hospitalized and nonhospitalized patients with COVID-19. J Allergy Clin Immunol 2020;146(2):307–314.e4. doi:https://doi.org/10.1016/j.jaci.2020.06.010.
- Wang L, Foer D, Bates DW, Boyce JA, Zhou L. Risk factors for hospitalization, intensive care and mortality among patients with asthma and COVID-19. J Allergy Clin Immunol. 2020;146(4):808–812. doi:https://doi.org/10.1016/j.jaci.2020.07.018.
- Zhu Z, Hasegawa K, Ma B, Fujiogi M, Camargo CA, Jr., Liang L. Association of asthma and its genetic predisposition with the risk of severe COVID-19. J Allergy Clin Immunol. 2020;146(2):327–329.e4. doi:https://doi.org/10.1016/j.jaci.2020.06.001.
- Ziegler CGK, Allon SJ, Nyquist SK, Mbano IM, Miao VN, Tzouanas CN, Cao Y, Yousif AS, Bals J, Hauser BM, HCA Lung Biological Network, et al. SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues. Cell. 2020;181(5):1016–1035.e19. doi:https://doi.org/10.1016/j.cell.2020.04.035.
- Camiolo MJ, Gauthier M, Kaminski N, Ray A, Wenzel SE. Expression of SARS-CoV-2 receptor ACE2 and coincident host response signature varies by asthma inflammatory phenotype. J Allergy Clin Immunol. 2020;146(2):315–324.e7. doi:https://doi.org/10.1016/j.jaci.2020.05.051.
- Bunyavanich S, Do A, Vicencio A. Nasal gene expression of angiotensin-converting enzyme 2 in children and adults. JAMA. 2020;323(23):2427–2429. doi:https://doi.org/10.1001/jama.2020.8707.
- Yamaya M, Nishimura H, Deng X, Sugawara M, Watanabe O, Nomura K, Shimotai Y, Momma H, Ichinose M, Kawase T, et al. Inhibitory effects of glycopyrronium, formoterol, and budesonide on coronavirus HCoV-229E replication and cytokine production by primary cultures of human nasal and tracheal epithelial cells. Respir Investig. 2020;58(3):155–168. doi:https://doi.org/10.1016/j.resinv.2019.12.005.
- Kimura H, Kurusu H, Sada M, Kurai D, Murakami K, Kamitani W, Tomita H, Katayama K, Ryo A. Molecular pharmacology of ciclesonide against SARS-CoV-2. J Allergy Clin Immunol. 2020;146(2):330–331. doi:https://doi.org/10.1016/j.jaci.2020.05.029.
- Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L, Staplin N, Brightling C, Ustianowski A, Elmahi E, et al. Dexamethasone in hospitalized patients with Covid-19 - preliminary report. N Engl J Med. Published online July 17, 2020; doi:https://doi.org/10.1056/NEJMoa2021436.
- Halpin DMG, Singh D, Hadfield RM. Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective. Eur Respir J. 2020;55(5):2001009. doi:https://doi.org/10.1183/13993003.01009-2020.
- Moore A. COVID-19 and asthma: what patients need to know [Internet]. 2020. The American Academy of Allergy, Asthma, and Immunology; [reviewed 2020 August; last accessed 2020 September 3]. Available from: https://www.aaaai.org/conditions-and-treatments/library/asthma-library/covid-asthma.